OCC 1.16% 42.5¢ orthocell limited

Ann: Remplir Gains Australian Reimbursement, page-55

  1. 787 Posts.
    lightbulb Created with Sketch. 126
    30 million would be well suited for future trials and manufacturing expansion. It would be crazy to waste a cent of it on a buy back. If revenues sky-rocket then it changes everything but in my opinion we will struggle to go cash flow positive in the next two years alone.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.